Introduction: Older adults are indisputably struck hard by the coronavirus disease 2019
(COVID-19) pandemic. The main objective of this meta-analysis is to establish the …

Background This study aimed to investigate whether the active prescription of low-dose
aspirin during or prior to hospitalization affects mortality in patients with coronavirus disease …

Background Thrombosis and inflammation may contribute to the risk of death and
complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized …

Objective To evaluate whether early initiation of prophylactic anticoagulation compared with
no anticoagulation was associated with decreased risk of death among patients admitted to …

Background Repurposing the use of aspirin to treat hospitalized patients with COVID-19 is a
sensible approach. However, several previous studies showed conflicting results. This meta …

Background and aims The idea of treating COVID-19 with statins is biologically plausible,
although it is still controversial. The systematic review and meta-analysis aimed to address …

Background Thrombosis may contribute to morbidity and mortality in Covid-19. We
hypothesized that therapeutic anticoagulation would improve outcomes in critically ill …

Hypercoagulability in coronavirus disease 2019 (COVID-19) may aggravate disease
severity during hospitalization but the reported survival benefits from anticoagulation (AC) …

Background The evidence of using JAK inhibitors among hospitalized patients with COVID-
19 is conflicting. The systematic review and meta-analysis aimed to address the efficacy of …

Background Anticoagulation in hospitalized COVID-19 patients has been associated with
survival benefit; however, the optimal anticoagulant strategy has not yet been defined. The …